About 30 agents have been shown to diminish liver cancer in experimental animals. For many of these, safety is well established, thus permitting intervention studies, and some agents are already being used in trials for anticarcinogenesis at other sites. An aspect that has received little attention and warrants further study is combination cancer prophylaxis.